Stodolna, Agata
He, Miao
Vasipalli, Mahesh
Kingsbury, Zoya
Becq, Jennifer
Stockton, Joanne D.
Dilworth, Mark P.
James, Jonathan
Sillo, Toju
Blakeway, Daniel
Ward, Stephen T.
Ismail, Tariq
Ross, Mark T.
Beggs, Andrew D. http://orcid.org/0000-0003-0784-2967
Funding for this research was provided by:
Cancer Research UK (C31641/A23923)
Wellcome Trust (102732/Z/13/Z)
Article History
Received: 29 April 2020
Accepted: 11 February 2021
First Online: 25 February 2021
Ethics approval and consent to participate
: All patients provided written informed consent to participate in the study and ethics approval for the study was granted by the University of Birmingham Human Biomaterials Resource Centre (HBRC, ethical approval ref. 15/NW/0079). The research conformed to the principles of the Helsinki Declaration.
: Not applicable
: AB has received travel costs and honoraria from Illumina Inc., Oxford Nanopore, Ono Pharm and Bristol Myers Squibb. MH, MV, ZK, JB and MR are employees of Illumina, a public company that develops and markets systems for genetic analysis. The remaining authors declare that they have no competing interests.